APO Research
Talk to an analyst

APO RESEARCH · REPORT

Methylation Analysis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Methylation Analysis Market Analysis and Forecast 2026-2032

17 January 2026198 pages

Choose your research edition.

Industry ResearchMethylation Analysis Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Methylation Analysis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Methylation Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Methylation Analysis Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Methylation Analysis Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Methylation Analysis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Methylation Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Methylation Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Methylation Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Methylation Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Methylation Analysis include Berry Genomics, Illumina Inc., Diagenode, Novogene, Qiagen N.V., Oebiotech, RiboBio, Merck KGaA and BGI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Methylation Analysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Methylation Analysis, also provides the revenue of main regions and countries. Of the upcoming market potential for Methylation Analysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Methylation Analysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Methylation Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Methylation Analysis revenue, projected growth trends, production technology, application and end-user industry.

Methylation Analysis Segment by Company

Berry Genomics

Illumina Inc.

Diagenode

Novogene

Qiagen N.V.

Oebiotech

RiboBio

Merck KGaA

BGI

Seqhealth

Zymo Research Corporation

Epigentek

Promega Corporation

CD Genomics

BioCat GmbH

Methylation Analysis Segment by Type

DNA Methylation Sequencing

RNA Methylation Sequencing

Methylation Analysis Segment by Application

Clinical

Laboratory

Others

Methylation Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methylation Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Methylation Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methylation Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Methylation Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Methylation Analysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methylation Analysis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Methylation Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DNA Methylation Sequencing Major Player Table 3. RNA Methylation Sequencing Major Player Table 4. Global Methylation Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinical Major Player Table 6. Laboratory Major Player Table 7. Others Major Player Table 8. Methylation Analysis Industry Trends Table 9. Methylation Analysis Industry Drivers Table 10. Methylation Analysis Industry Opportunities and Challenges Table 11. Methylation Analysis Industry Restraints Table 12. Global Methylation Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Methylation Analysis Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Methylation Analysis Market Share by Region (2021-2026) Table 15. Global Methylation Analysis Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Methylation Analysis Market Share by Region (2027-2032) Table 17. Global Methylation Analysis Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Methylation Analysis Revenue Market Share by Players (2021-2026) Table 19. Global Methylation Analysis Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Methylation Analysis Key Players Headquarters & Area Served Table 21. Global Methylation Analysis Players, Product Type & Application Table 22. Global Methylation Analysis Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Methylation Analysis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Methylation Analysis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Methylation Analysis Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Methylation Analysis Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Methylation Analysis Revenue Market Share by Type (2021-2026) Table 29. Global Methylation Analysis Revenue Market Share by Type (2027-2032) Table 30. Global Methylation Analysis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Methylation Analysis Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Methylation Analysis Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Methylation Analysis Revenue Market Share by Application (2021-2026) Table 34. Global Methylation Analysis Revenue Market Share by Application (2027-2032) Table 35. Berry Genomics Company Information Table 36. Berry Genomics Business Overview Table 37. Berry Genomics Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Berry Genomics Methylation Analysis Product Portfolio Table 39. Berry Genomics Recent Development Table 40. Illumina Inc. Company Information Table 41. Illumina Inc. Business Overview Table 42. Illumina Inc. Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Illumina Inc. Methylation Analysis Product Portfolio Table 44. Illumina Inc. Recent Development Table 45. Diagenode Company Information Table 46. Diagenode Business Overview Table 47. Diagenode Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Diagenode Methylation Analysis Product Portfolio Table 49. Diagenode Recent Development Table 50. Novogene Company Information Table 51. Novogene Business Overview Table 52. Novogene Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novogene Methylation Analysis Product Portfolio Table 54. Novogene Recent Development Table 55. Qiagen N.V. Company Information Table 56. Qiagen N.V. Business Overview Table 57. Qiagen N.V. Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Qiagen N.V. Methylation Analysis Product Portfolio Table 59. Qiagen N.V. Recent Development Table 60. Oebiotech Company Information Table 61. Oebiotech Business Overview Table 62. Oebiotech Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Oebiotech Methylation Analysis Product Portfolio Table 64. Oebiotech Recent Development Table 65. RiboBio Company Information Table 66. RiboBio Business Overview Table 67. RiboBio Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. RiboBio Methylation Analysis Product Portfolio Table 69. RiboBio Recent Development Table 70. Merck KGaA Company Information Table 71. Merck KGaA Business Overview Table 72. Merck KGaA Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Merck KGaA Methylation Analysis Product Portfolio Table 74. Merck KGaA Recent Development Table 75. BGI Company Information Table 76. BGI Business Overview Table 77. BGI Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BGI Methylation Analysis Product Portfolio Table 79. BGI Recent Development Table 80. Seqhealth Company Information Table 81. Seqhealth Business Overview Table 82. Seqhealth Methylation Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Seqhealth Methylation Analysis Product Portfolio Table 84. Seqhealth Recent Development Table 85. Zymo Research Corporation Company Information Table 86. Zymo Research Corporation Business Overview Table 87. Zymo Research Corporation Methylation Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Zymo Research Corporation Methylation Analysis Product Portfolio Table 89. Zymo Research Corporation Recent Development Table 90. Epigentek Company Information Table 91. Epigentek Business Overview Table 92. Epigentek Methylation Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Epigentek Methylation Analysis Product Portfolio Table 94. Epigentek Recent Development Table 95. Promega Corporation Company Information Table 96. Promega Corporation Business Overview Table 97. Promega Corporation Methylation Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Promega Corporation Methylation Analysis Product Portfolio Table 99. Promega Corporation Recent Development Table 100. CD Genomics Company Information Table 101. CD Genomics Business Overview Table 102. CD Genomics Methylation Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. CD Genomics Methylation Analysis Product Portfolio Table 104. CD Genomics Recent Development Table 105. BioCat GmbH Company Information Table 106. BioCat GmbH Business Overview Table 107. BioCat GmbH Methylation Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. BioCat GmbH Methylation Analysis Product Portfolio Table 109. BioCat GmbH Recent Development Table 110. North America Methylation Analysis Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Methylation Analysis Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Methylation Analysis Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Methylation Analysis Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Methylation Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Methylation Analysis Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Methylation Analysis Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Methylation Analysis Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Methylation Analysis Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Methylation Analysis Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Methylation Analysis Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Methylation Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Methylation Analysis Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Methylation Analysis Revenue by Country (US$ Million) & (2027-2032) Table 124. China Methylation Analysis Revenue by Type (2021-2026) & (US$ Million) Table 125. China Methylation Analysis Revenue by Type (2027-2032) & (US$ Million) Table 126. China Methylation Analysis Revenue by Application (2021-2026) & (US$ Million) Table 127. China Methylation Analysis Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Methylation Analysis Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Methylation Analysis Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Methylation Analysis Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Methylation Analysis Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Methylation Analysis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Methylation Analysis Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Methylation Analysis Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Methylation Analysis Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Methylation Analysis Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Methylation Analysis Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Methylation Analysis Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Methylation Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Methylation Analysis Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Methylation Analysis Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Methylation Analysis Image Figure 2. Global Methylation Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Methylation Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 4. DNA Methylation Sequencing Image Figure 5. RNA Methylation Sequencing Image Figure 6. Global Methylation Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Methylation Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinical Image Figure 9. Laboratory Image Figure 10. Others Image Figure 11. Global Methylation Analysis Market Size (US$ Million) & (2021-2032) Figure 12. Global Methylation Analysis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Methylation Analysis Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Methylation Analysis Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Methylation Analysis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Methylation Analysis Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Methylation Analysis Revenue Market Share by Type (2021-2032) Figure 19. Global Methylation Analysis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Methylation Analysis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Methylation Analysis Revenue Market Share by Application (2021-2032) Figure 22. North America Methylation Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Methylation Analysis Revenue Share by Type (2021-2032) Figure 24. North America Methylation Analysis Revenue Share by Application (2021-2032) Figure 25. North America Methylation Analysis Revenue Share by Country (2021-2032) Figure 26. United States Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Methylation Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Methylation Analysis Revenue Share by Type (2021-2032) Figure 31. Europe Methylation Analysis Revenue Share by Application (2021-2032) Figure 32. Europe Methylation Analysis Revenue Share by Country (2021-2032) Figure 33. Germany Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Methylation Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Methylation Analysis Revenue Share by Type (2021-2032) Figure 43. China Methylation Analysis Revenue Share by Application (2021-2032) Figure 44. Asia Methylation Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Methylation Analysis Revenue Share by Type (2021-2032) Figure 46. Asia Methylation Analysis Revenue Share by Application (2021-2032) Figure 47. Asia Methylation Analysis Revenue Share by Region (2021-2032) Figure 48. Japan Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Methylation Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Methylation Analysis Revenue Share by Type (2021-2032) Figure 56. SAMEA Methylation Analysis Revenue Share by Application (2021-2032) Figure 57. SAMEA Methylation Analysis Revenue Share by Country (2021-2032) Figure 58. Brazil Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Methylation Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Sequencing
  • RNA Methylation Sequencing
Applications
  • Clinical
  • Laboratory
  • Others
Companies covered
  • Berry Genomics
  • Illumina Inc.
  • Diagenode
  • Novogene
  • Qiagen N.V.
  • Oebiotech
  • RiboBio
  • Merck KGaA
  • BGI
  • Seqhealth
  • Zymo Research Corporation
  • Epigentek
  • Promega Corporation
  • CD Genomics
  • BioCat GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Methylation Analysis Market by Type
  3. 1.2.1 Global Methylation Analysis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Methylation Sequencing
  5. 1.2.3 RNA Methylation Sequencing
  6. 1.3 Methylation Analysis Market by Application
  7. 1.3.1 Global Methylation Analysis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinical
  9. 1.3.3 Laboratory
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Methylation Analysis Market Dynamics
  1. 2.1 Methylation Analysis Industry Trends
  2. 2.2 Methylation Analysis Industry Drivers
  3. 2.3 Methylation Analysis Industry Opportunities and Challenges
  4. 2.4 Methylation Analysis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Methylation Analysis Market Perspective (2021-2032)
  2. 3.2 Global Methylation Analysis Growth Trends by Region
  3. 3.2.1 Global Methylation Analysis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Methylation Analysis Market Size by Region (2021-2026)
  5. 3.2.3 Global Methylation Analysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Methylation Analysis Revenue by Players
  2. 4.1.1 Global Methylation Analysis Revenue by Players (2021-2026)
  3. 4.1.2 Global Methylation Analysis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Methylation Analysis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Methylation Analysis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Methylation Analysis Key Players Headquarters & Area Served
  7. 4.4 Global Methylation Analysis Players, Product Type & Application
  8. 4.5 Global Methylation Analysis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Methylation Analysis Market CR5 and HHI
  11. 4.6.3 2025 Methylation Analysis Tier 1, Tier 2, and Tier 3
5 Methylation Analysis Market Size by Type
  1. 5.1 Global Methylation Analysis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Methylation Analysis Revenue by Type (2021-2032)
  3. 5.3 Global Methylation Analysis Revenue Market Share by Type (2021-2032)
6 Methylation Analysis Market Size by Application
  1. 6.1 Global Methylation Analysis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Methylation Analysis Revenue by Application (2021-2032)
  3. 6.3 Global Methylation Analysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Berry Genomics
  2. 7.1.1 Berry Genomics Company Information
  3. 7.1.2 Berry Genomics Business Overview
  4. 7.1.3 Berry Genomics Methylation Analysis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Berry Genomics Methylation Analysis Product Portfolio
  6. 7.1.5 Berry Genomics Recent Developments
  7. 7.2 Illumina Inc.
  8. 7.2.1 Illumina Inc. Company Information
  9. 7.2.2 Illumina Inc. Business Overview
  10. 7.2.3 Illumina Inc. Methylation Analysis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Illumina Inc. Methylation Analysis Product Portfolio
  12. 7.2.5 Illumina Inc. Recent Developments
  13. 7.3 Diagenode
  14. 7.3.1 Diagenode Company Information
  15. 7.3.2 Diagenode Business Overview
  16. 7.3.3 Diagenode Methylation Analysis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Diagenode Methylation Analysis Product Portfolio
  18. 7.3.5 Diagenode Recent Developments
  19. 7.4 Novogene
  20. 7.4.1 Novogene Company Information
  21. 7.4.2 Novogene Business Overview
  22. 7.4.3 Novogene Methylation Analysis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novogene Methylation Analysis Product Portfolio
  24. 7.4.5 Novogene Recent Developments
  25. 7.5 Qiagen N.V.
  26. 7.5.1 Qiagen N.V. Company Information
  27. 7.5.2 Qiagen N.V. Business Overview
  28. 7.5.3 Qiagen N.V. Methylation Analysis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Qiagen N.V. Methylation Analysis Product Portfolio
  30. 7.5.5 Qiagen N.V. Recent Developments
  31. 7.6 Oebiotech
  32. 7.6.1 Oebiotech Company Information
  33. 7.6.2 Oebiotech Business Overview
  34. 7.6.3 Oebiotech Methylation Analysis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Oebiotech Methylation Analysis Product Portfolio
  36. 7.6.5 Oebiotech Recent Developments
  37. 7.7 RiboBio
  38. 7.7.1 RiboBio Company Information
  39. 7.7.2 RiboBio Business Overview
  40. 7.7.3 RiboBio Methylation Analysis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 RiboBio Methylation Analysis Product Portfolio
  42. 7.7.5 RiboBio Recent Developments
  43. 7.8 Merck KGaA
  44. 7.8.1 Merck KGaA Company Information
  45. 7.8.2 Merck KGaA Business Overview
  46. 7.8.3 Merck KGaA Methylation Analysis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merck KGaA Methylation Analysis Product Portfolio
  48. 7.8.5 Merck KGaA Recent Developments
  49. 7.9 BGI
  50. 7.9.1 BGI Company Information
  51. 7.9.2 BGI Business Overview
  52. 7.9.3 BGI Methylation Analysis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BGI Methylation Analysis Product Portfolio
  54. 7.9.5 BGI Recent Developments
  55. 7.10 Seqhealth
  56. 7.10.1 Seqhealth Company Information
  57. 7.10.2 Seqhealth Business Overview
  58. 7.10.3 Seqhealth Methylation Analysis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Seqhealth Methylation Analysis Product Portfolio
  60. 7.10.5 Seqhealth Recent Developments
  61. 7.11 Zymo Research Corporation
  62. 7.11.1 Zymo Research Corporation Company Information
  63. 7.11.2 Zymo Research Corporation Business Overview
  64. 7.11.3 Zymo Research Corporation Methylation Analysis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Zymo Research Corporation Methylation Analysis Product Portfolio
  66. 7.11.5 Zymo Research Corporation Recent Developments
  67. 7.12 Epigentek
  68. 7.12.1 Epigentek Company Information
  69. 7.12.2 Epigentek Business Overview
  70. 7.12.3 Epigentek Methylation Analysis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Epigentek Methylation Analysis Product Portfolio
  72. 7.12.5 Epigentek Recent Developments
  73. 7.13 Promega Corporation
  74. 7.13.1 Promega Corporation Company Information
  75. 7.13.2 Promega Corporation Business Overview
  76. 7.13.3 Promega Corporation Methylation Analysis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Promega Corporation Methylation Analysis Product Portfolio
  78. 7.13.5 Promega Corporation Recent Developments
  79. 7.14 CD Genomics
  80. 7.14.1 CD Genomics Company Information
  81. 7.14.2 CD Genomics Business Overview
  82. 7.14.3 CD Genomics Methylation Analysis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CD Genomics Methylation Analysis Product Portfolio
  84. 7.14.5 CD Genomics Recent Developments
  85. 7.15 BioCat GmbH
  86. 7.15.1 BioCat GmbH Company Information
  87. 7.15.2 BioCat GmbH Business Overview
  88. 7.15.3 BioCat GmbH Methylation Analysis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BioCat GmbH Methylation Analysis Product Portfolio
  90. 7.15.5 BioCat GmbH Recent Developments
8 North America
  1. 8.1 North America Methylation Analysis Revenue (2021-2032)
  2. 8.2 North America Methylation Analysis Revenue by Type (2021-2032)
  3. 8.2.1 North America Methylation Analysis Revenue by Type (2021-2026)
  4. 8.2.2 North America Methylation Analysis Revenue by Type (2027-2032)
  5. 8.3 North America Methylation Analysis Revenue Share by Type (2021-2032)
  6. 8.4 North America Methylation Analysis Revenue by Application (2021-2032)
  7. 8.4.1 North America Methylation Analysis Revenue by Application (2021-2026)
  8. 8.4.2 North America Methylation Analysis Revenue by Application (2027-2032)
  9. 8.5 North America Methylation Analysis Revenue Share by Application (2021-2032)
  10. 8.6 North America Methylation Analysis Revenue by Country
  11. 8.6.1 North America Methylation Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Methylation Analysis Revenue by Country (2021-2026)
  13. 8.6.3 North America Methylation Analysis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Methylation Analysis Revenue (2021-2032)
  2. 9.2 Europe Methylation Analysis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Methylation Analysis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Methylation Analysis Revenue by Type (2027-2032)
  5. 9.3 Europe Methylation Analysis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Methylation Analysis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Methylation Analysis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Methylation Analysis Revenue by Application (2027-2032)
  9. 9.5 Europe Methylation Analysis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Methylation Analysis Revenue by Country
  11. 9.6.1 Europe Methylation Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Methylation Analysis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Methylation Analysis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Methylation Analysis Revenue (2021-2032)
  2. 10.2 China Methylation Analysis Revenue by Type (2021-2032)
  3. 10.2.1 China Methylation Analysis Revenue by Type (2021-2026)
  4. 10.2.2 China Methylation Analysis Revenue by Type (2027-2032)
  5. 10.3 China Methylation Analysis Revenue Share by Type (2021-2032)
  6. 10.4 China Methylation Analysis Revenue by Application (2021-2032)
  7. 10.4.1 China Methylation Analysis Revenue by Application (2021-2026)
  8. 10.4.2 China Methylation Analysis Revenue by Application (2027-2032)
  9. 10.5 China Methylation Analysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Methylation Analysis Revenue (2021-2032)
  2. 11.2 Asia Methylation Analysis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Methylation Analysis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Methylation Analysis Revenue by Type (2027-2032)
  5. 11.3 Asia Methylation Analysis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Methylation Analysis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Methylation Analysis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Methylation Analysis Revenue by Application (2027-2032)
  9. 11.5 Asia Methylation Analysis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Methylation Analysis Revenue by Country
  11. 11.6.1 Asia Methylation Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Methylation Analysis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Methylation Analysis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Methylation Analysis Revenue (2021-2032)
  2. 12.2 SAMEA Methylation Analysis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Methylation Analysis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Methylation Analysis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Methylation Analysis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Methylation Analysis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Methylation Analysis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Methylation Analysis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Methylation Analysis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Methylation Analysis Revenue by Country
  11. 12.6.1 SAMEA Methylation Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Methylation Analysis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Methylation Analysis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst